Latest news
AstraZeneca’s Datroway wins EU approval as first TROP2-directed therapy for breast cancer - Indian Pharma PostIndian Pharma Post · Wed, 05 Aug 2026 14:18:22 GMTDatroway Wins EU Approval for First-Line Metastatic Triple-Negative Breast Cancer - BioPharm InternationalBioPharm International · Fri, 31 Jul 2026 17:17:31 GMTDaiichi Sankyo wins EU approval for Datroway in TNBC - jp.ibtimes.comjp.ibtimes.com · Fri, 31 Jul 2026 16:15:40 GMTEU approves Datroway as first TROP2 ADC with overall survival benefit in first-line metastatic TNBC - AllSciAllSci · Fri, 31 Jul 2026 12:33:31 GMTAstraZeneca, Daiichi Sankyo’s Datroway approved in EU - TipRanksTipRanks · Fri, 31 Jul 2026 11:36:59 GMTAstraZeneca (NASDAQ: AZN) gains EU nod for Datroway in metastatic TNBC - Stock TitanStock Titan · Fri, 31 Jul 2026 10:54:32 GMTAstraZeneca and Daiichi win EU label expansion for Datroway in breast cancer - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 10:53:54 GMTAstraZeneca's and Daiichi's Datroway wins EU breast cancer approval - London South EastLondon South East · Fri, 31 Jul 2026 08:49:00 GMT